SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-20-163701
Filing Date
2020-06-08
Accepted
2020-06-08 17:21:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D d941679dsc13d.htm SC 13D 43579
  Complete submission text file 0001193125-20-163701.txt   45247
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Subject) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88225 | Film No.: 20950050
SIC: 2834 Pharmaceutical Preparations

Mailing Address 150 MONUMENT ROAD, SUITE 207 BALA CYNWYD PA 19004
Business Address 150 MONUMENT ROAD, SUITE 207 BALA CYNWYD PA 19004 844-511-9056
CHONDRIAL THERAPEUTICS HOLDINGS, LLC (Filed by) CIK: 0001776691 (see all company filings)

IRS No.: 814489294 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D